Ultra Nasdaq Biotechnology Proshares (BIB) 158.26

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ultra Nasdaq Biotechnology Proshares (BIB) 158.26 $BIB

Biotech selling off early
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 9:04AM CST

BIB: 158.26 (-4.88), IBB: 342.36 (-5.31)

Ugly day for biotech
Seeking Alpha - at Seeking Alpha - Thu Jan 15, 1:03PM CST

BIB: 158.26 (-4.88), IBB: 342.36 (-5.31)

Biotech off to a good start on first trading day of 2015
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 8:57AM CST

BIB: 158.26 (-4.88), IBB: 342.36 (-5.31)

Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers
Peter F. Way, CFA - Seeking Alpha - Wed Dec 24, 8:33AM CST
This is a market price forecast analysis It is not an analysis of medical technology, competition, or economics. We have limited competence in those areas. But we do have extensive experience in how market professionals have interpreted the likely...
ESRX: 82.27 (-2.01), GILD: 101.81 (-1.61), FBT: 118.67 (-1.54), BIB: 158.26 (-4.88), XBI: 224.72 (-2.85), IBB: 342.36 (-5.31), BBH: 130.03 (-2.40), ABBV: 55.64 (-1.22)

Look for Shares of ProShares Ultra Nasdaq Biotechnology ETF to Potentially Rebound after Yesterday's 9.20% Sell Off
Comtex SmarTrend(R) - Tue Dec 23, 5:13PM CST
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $116.34 to a high of $131.99. Yesterday, the shares fell 9.2%, which took the trading range below the 3-day low of $128.10 on volume of 948,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 158.26 (-4.88)

Money flowing out of biotech today
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 9:40AM CST

BIS: 35.17 (+1.04), ESRX: 82.27 (-2.01), GILD: 101.81 (-1.61), BIB: 158.26 (-4.88), IBB: 342.36 (-5.31), ABBV: 55.64 (-1.22)

ProShares Ultra Nasdaq Biotechnology ETF Has Returned 22.8% Since SmarTrend Recommendation (BIB)
Comtex SmarTrend(R) - Mon Dec 15, 9:19AM CST
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on October 21st, 2014 at $104.76. In approximately 2 months, ProShares Ultra Nasdaq Biotechnology ETF has returned 22.84% as of today's recent price of $128.68.
BIB: 158.26 (-4.88)

25.1% Return Seen to Date on SmarTrend ProShares Ultra Nasdaq Biotechnology ETF Call (BIB)
Comtex SmarTrend(R) - Fri Dec 05, 4:55PM CST
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on October 21st, 2014 at $104.76. In approximately 2 month, ProShares Ultra Nasdaq Biotechnology ETF has returned 25.05% as of today's recent price of $131.00.
BIB: 158.26 (-4.88)

Shares of BIB Up 23.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 28, 11:03AM CST
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on October 21st, 2014 at $104.76. In approximately 1 month, ProShares Ultra Nasdaq Biotechnology ETF has returned 23.28% as of today's recent price of $129.14.
BIB: 158.26 (-4.88)

Vargatef cleared in Europe for lung cancer
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 8:23AM CST

HTBX: 7.35 (+0.53), BIB: 158.26 (-4.88), INCY: 90.00 (-1.97), PFE: 33.97 (-0.50), IBB: 342.36 (-5.31), DRGS: 59.23 (unch), BIND: 5.96 (+0.02), BMY: 65.12 (-0.93), GSK: 46.73 (-0.87), ONTY: 1.58 (-0.03), ECYT: 6.21 (-0.04), BIS: 35.17 (+1.04), CLVS: 79.19 (-0.47), AZN: 66.27 (-1.91), MRK: 56.84 (-1.14), ARIA: 8.08 (-0.17), IRY: 50.78 (-0.56), IXJ: 105.25 (-1.97), FPRX: 24.55 (-1.09)

UniQure sets price record with Glybera
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 2:33PM CST

BIS: 35.17 (+1.04), QURE: 24.62 (+1.77), BIB: 158.26 (-4.88), ALXN: 181.65 (-4.14), IBB: 342.36 (-5.31)

China mulling eliminating drug price controls
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 6:17AM CST

EWH: 21.43 (-0.08), PEK: 44.28 (-0.73), CNXT: 35.06 (-1.28), KBA: 45.17 (-0.68), BIB: 158.26 (-4.88), CQQQ: 37.20 (-0.63), IBB: 342.36 (-5.31), DRGS: 59.23 (unch), CHXF: 52.84 (-0.03), YINN: 33.91 (-1.19), FXP: 41.95 (+0.91), EWHS: 26.58 (-0.70), PGJ: 28.58 (-0.19), FCA: 23.22 (-0.11), YAO: 27.52 (-0.18), FCHI: 51.51 (-0.29), ASHR: 35.00 (-0.45), ASHS: 39.91 (-0.87), GXC: 79.68 (-0.79), FXI: 41.26 (-0.44), XPP: 67.52 (-1.55), KWEB: 33.05 (-0.01), ECNS: 45.11 (-0.14), TAO: 20.90 (-0.12), CHNA: 33.88 (-0.26), QQQC: 21.88 (+0.16), CHIX: 14.89 (-0.16), KFYP: 64.07 (unch), HAO: 25.51 (-0.09), MCHI: 50.65 (-0.55), CHIM: 15.14 (unch), YANG: 11.13 (+0.35), BIS: 35.17 (+1.04), CHIQ: 12.71 (-0.07), CHIE: 13.19 (unch), FHK: 40.63 (-0.25), CHII: 13.64 (-0.09), YXI: 27.85 (unch), CN: 34.30 (-0.43)

Drug makers face pushback on pricey meds
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 7:18AM CST

ABT: 46.50 (-0.94), BIIB: 417.63 (-7.98), BIB: 158.26 (-4.88), PFE: 33.97 (-0.50), AMGN: 154.88 (-4.72), IBB: 342.36 (-5.31), LLY: 68.41 (-2.18), DRGS: 59.23 (unch), GSK: 46.73 (-0.87), BMY: 65.12 (-0.93), CELG: 118.03 (-2.68), JNJ: 100.11 (-2.41), ESRX: 82.27 (-2.01), BIS: 35.17 (+1.04), MRK: 56.84 (-1.14), AZN: 66.27 (-1.91), CVS: 101.90 (-1.46), ABBV: 55.64 (-1.22), SNY: 47.42 (-0.94), IRY: 50.78 (-0.56), IXJ: 105.25 (-1.97), NVS: 97.46 (-1.49)

Histogenics on deck for IPO
Seeking Alpha - at Seeking Alpha - Mon Nov 24, 3:30PM CST

IPO: 23.93 (-0.31), BIS: 35.17 (+1.04), BIB: 158.26 (-4.88), IBB: 342.36 (-5.31)

CB Pharma on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 10:46AM CST

IPO: 23.93 (-0.31), BIS: 35.17 (+1.04), BIB: 158.26 (-4.88), CNDO: 3.28 (-0.09), IBB: 342.36 (-5.31), DRGS: 59.23 (unch), IXJ: 105.25 (-1.97), IRY: 50.78 (-0.56)

CF Foundation sells royalties for $3.3B
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 7:03AM CST

BIS: 35.17 (+1.04), VRTX: 126.34 (-0.62), BIB: 158.26 (-4.88), IBB: 342.36 (-5.31), DRGS: 59.23 (unch), IXJ: 105.25 (-1.97), IRY: 50.78 (-0.56)

Global drug tab will breach trillion dollar mark this year
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 6:41AM CST

BIS: 35.17 (+1.04), IMS: 25.81 (-0.46), PCYC: 254.56 (+0.34), GILD: 101.81 (-1.61), BIB: 158.26 (-4.88), IBB: 342.36 (-5.31), AMGN: 154.88 (-4.72), DRGS: 59.23 (unch), IXJ: 105.25 (-1.97), IRY: 50.78 (-0.56)

Second Sight begins trading today
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 8:42AM CST

IPO: 23.93 (-0.31), EYES: 17.44 (+0.37), BIS: 35.17 (+1.04), BIB: 158.26 (-4.88), IBB: 342.36 (-5.31)

Neothetics on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 12:46PM CST

IPO: 23.93 (-0.31), BIS: 35.17 (+1.04), BIB: 158.26 (-4.88), IBB: 342.36 (-5.31)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Indiana Michigan Power Expands Energy Reach with Acquisition

Updated Category News Views 253

I&M Plans for Sustainable Energy Future Indiana Michigan Power (I&M), part of American Electric Power (NASDAQ: AEP), is making significant strides towards bolstering its energy infrastructure. Recently receiving approval from the Indiana Utility Regulatory Commission (IURC) to acquire the Oregon Clean Energy Center, I&M is focused on delivering reliable and affordable...

Continue Reading
Enhance Your Breathing: Discover Naväge's New SaltPods

Updated Category News Views 163

Breathe Easier Every Day with Naväge® SaltPods The new SaltPods from Naväge feature essential oils combined with saline solution to amplify the nasal rinsing experience and support better breathing throughout the day. Introducing Innovative Nasal Rinsing Solutions Naväge®, a trusted leader in drug-free nasal care, has introduced an exciting addition to wellness...

Continue Reading
O2Gold Increases Financing While Finalizing Quebec Acquisition

Updated Category News Views 185

O2Gold Updates on Major Acquisition and Financing Strategy O2Gold Inc. (NASDAQ: OTGO) is excited to share recent developments regarding its acquisition of a gold mining exploration property in Quebec. This deal involves purchasing all outstanding shares of Quebec Aur Ltd., a move aligned with O2Gold's vision of expanding its mining portfolio. Details on the Acquisition...

Continue Reading
SKYX Technologies Secures $4 Million Preferred Stock Funding

Updated Category News Views 254

SKYX Technologies Secures Significant Funding for Growth MIAMI — SKYX (NASDAQ: SKYX), a leader in smart home platform technologies, has made headlines by securing approximately $4 million in preferred stock funding. This investment comes from strategic investors who purchased shares at a value of $2.00 each. This move is part of a larger financing round, bringing the...

Continue Reading
Coinbase CEO Armstrong's Recent Share Sale Shakes Market

Updated Category News Views 145

Coinbase CEO's Share Sale Influences Market Dynamics Coinbase Global Inc (NASDAQ: COIN) recently experienced a notable decline from its three-year high. This shift occurred following the announcement that CEO Brian Armstrong sold approximately $300 million worth of shares, marking the second major share sale in November. Investors closely follow such transactions, as they...

Continue Reading